A look at Malta’s most vibrant industries and economic successes with insights from local Partner Dr. Vassilis Trochalidis of Boyden Greece, Cyprus and Malta.
Lower demand for COVID-19 vaccines means financial strain for biotech firms, particularly startups, but pharmaceutical giants are eyeing acquisition targets.
An interview with Alistair Kirk, transformation programme expert and member of the UK’s Vaccine Taskforce.
How can global business leaders deliver on ambitions of growth and reinvention?
Gil Carrara, U.S. Managing Partner and Healthcare & Life Sciences Regional Leader, discusses new strategic opportunities stemming from the health and wellness sector this year.
The biotech industry has expanded rapidly in the past decade, with investment in biotechnology and pharmaceutical firms pouring in from venture capitalists.
Going virtual – how COVID has accelerated a real shift in clinical trial methodology
Having risen to the COVID-19 challenge and reaped financial gains, firms could invest in R&D and grow their share in the global biotechnology market.
